Ramucirumab Intravenous and Suclear
Determining the interaction of Ramucirumab Intravenous and Suclear and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
Generic Name: polyethylene glycol 3350 with electrolytes
Brand name: Suclear, Colyte with Flavor Packs, GaviLyte-C, GoLYTELY, MoviPrep, NuLYTELY Orange, NuLYTELY with Flavor Packs, PEG-3350 with Electolytes, Plenvu, TriLyte with Flavor Packs, NuLYTELY, TriLyte
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ramucirumab Intravenous-Sucralfate
- Ramucirumab Intravenous-Sucralfate Oral Suspension
- Ramucirumab Intravenous-Sucralfate Suspension
- Ramucirumab Intravenous-Sucralfate Tablet
- Ramucirumab Intravenous-Sucralfate Tablets
- Ramucirumab Intravenous-Sucrets 4-Hour Cough Drops
- Suclear-Ranexa
- Suclear-Ranibizumab
- Suclear-Ranibizumab Intraocular
- Suclear-Ranibizumab ophthalmic
- Suclear-Ranitidine
- Suclear-Ranitidine Capsule